Litcius/Paper detail

The Molecular Impact of Glucosylceramidase Beta 1 (Gba1) in Parkinson’s Disease: a New Genetic State of the Art

Júlio César Claudino dos Santos, Gabriela Braga Cabrera Mano, André Rodrigues da Cunha Barreto Vianna, Túlia Fernanda Meira Garcia, Aline Vieira de Vasconcelos, Caio Sérgio Gomes Sá, Sarah Santana, Ana Gabriela Ponte Farias, Beatriz Seimaru, Micael Porto Portela Lima, João Vitor Caetano Goes, Camilla Teixeira Pinheiro Gusmão, Howard Lopes Ribeiro

2024Molecular Neurobiology19 citationsDOI

Topics & Concepts

GlucocerebrosidaseParkinson's diseaseDiseaseNeuroscienceAlpha-synucleinPopulationDementiaMedicineBioinformaticsGeneticsBiologyPathologyEnvironmental healthLysosomal Storage Disorders ResearchCellular transport and secretionParkinson's Disease Mechanisms and Treatments
The Molecular Impact of Glucosylceramidase Beta 1 (Gba1) in Parkinson’s Disease: a New Genetic State of the Art | Litcius